Clinical Trials Logo

Filter by:
NCT ID: NCT04883736 Completed - Acne Vulgaris Clinical Trials

A Study Comparing Tretinoin Gel Microsphere, 0.1% and RETIN-A MICRO ® Gel Microsphere, 0.1% in the Treatment of Acne Vulgaris

Start date: August 31, 2020
Phase: Early Phase 1
Study type: Interventional

To demonstrate the therapeutic equivalence and safety of Tretinoin Gel Microsphere, 0.1% (Taro Pharmaceuticals U.S.A, Inc.) and RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.1% (Valeant) in the treatment of acne vulgaris.

NCT ID: NCT04883593 Completed - Tinea Pedis Clinical Trials

A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis.

Start date: September 3, 2020
Phase: Early Phase 1
Study type: Interventional

To evaluate and compare the safety and efficacy of TA103 in the treatment of tinea pedis.

NCT ID: NCT04883528 Completed - Covid19 Clinical Trials

Protecting With ARNI Against Cardiac Consequences of Coronavirus Disease 2019

PARACOR-19
Start date: August 6, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine the effect of sacubitril/valsartan versus placebo on markers of cardiac injury, structure, and function among patients who recovered from acute COVID-19 infection.

NCT ID: NCT04883346 Completed - Obesity Clinical Trials

Liraglutide (Saxenda(R)) in Adolescents With Obesity After Sleeve Gastrectomy

Start date: June 21, 2021
Phase: Phase 2
Study type: Interventional

Background: Metabolic Bariatric Surgery, including a surgery called vertical sleeve gastrectomy, is the most effective weight loss treatment for severe obesity. However, many adolescents who have this surgery still have obesity 1 year later or regain weight. Researchers want to see if a drug can help. Objective: To learn if liraglutide can help adolescents who still have obesity 1 year or more after vertical sleeve gastrectomy lose additional weight. Eligibility: Healthy adolescents ages 12-20.99 years who are 1-10 years post vertical sleeve gastrectomy and have a BMI of 30 kg/m2 or >=95th percentile for age and sex. Design: Participants will be screened with: Medical history Physical exam Questionnaires about their mood and feelings about their weight Blood and urine tests Nutrition counseling. They will keep a diet log. A test where they view and respond to pictures of food Wrist accelerometer set-up. They will wear an accelerometer (a device like a watch) on their wrist for 14 days. It will measure their physical activity. Some screening tests will be repeated during the study. Participants will have an oral glucose tolerance test. They will ingest a sweet liquid. Blood samples will be taken. Participants will take liraglutide daily for 16 weeks. They will learn how to inject it under their skin. Participants will have a body scan to measure muscle and fat. Participants will be invited to eat as much as they want at a buffet meal at NIH. How much food they eat will be calculated. They will assess their appetite and mood before and after the meal. Participation will last for 7 months. Participants will have 7 study visits....

NCT ID: NCT04883307 Completed - Clinical trials for Burnout, Professional

Investigating the Impact of Professional Development Coaching Programs in Residents & Fellows

Start date: August 1, 2018
Phase: N/A
Study type: Interventional

The goal of the Professional Development Coaching Program is to allow trainees to understand their development over time, find meaning and purpose in their work, and identify their strengths and how to use these to overcome challenges and stressors. Additionally, the program connects trainees with a faculty member who will work with them, grow to know them in-depth over time, and provide meaningful guidance throughout the relationship. There is an additional benefit to the coaches themselves, who are able to connect with other faculty coaches in a rewarding way, that provides faculty development in leadership development and positive psychology, and space to interact with a group of like-minded physicians.

NCT ID: NCT04883099 Completed - Myopia Clinical Trials

APIOC for Presbyopia and APIOC for Presbyopia With Astigmatism

Start date: May 6, 2021
Phase: N/A
Study type: Interventional

Vision and comfort, both objective and subjective, will be assessed for single vision contact lens wearers for either the APIOCâ„¢ for Presbyopia or the APIOCâ„¢ for Presbyopia Astigmatism contact lenses.

NCT ID: NCT04883060 Completed - Clinical trials for Ventriculo-Peritoneal Shunt Infection

Pilot Testing for Midline Measuring Device

MMD
Start date: January 1, 2019
Phase: N/A
Study type: Interventional

Identifying the exact middling on the patient's head during the planning phase of surgery is crucial yet can be challenged by patient's head position and hair. The investigators have invented a device that uses anatomical landmark to quickly and gracefully identify the midline on a patient's head. The device is a U-shaped instrument equipped with a laser pointer at the midline. The instrument also has smooth spheres that can be positioned over the patients' ears bilaterally. The midline laser pointer will identify the midline on the patients' head. this measurement procedure is typically done after the patient is placed under anesthesia. The standard way of determining the midline on the skull is simply by surgeon's vision without any measurements. This new technique will be contrasted against the standard way. The device was invented by investigators in neurosurgery (led by Dr. Matthew Howard III). This is not patented it at this time. There is no company involved in manufacturing (assembly was completed with the help of the hospital's machine shop).

NCT ID: NCT04882995 Completed - Constipation Clinical Trials

Effect of Preoperative Fiber on Postoperative Bowel Function

Start date: May 13, 2019
Phase: N/A
Study type: Interventional

Post-operative constipation is one of the most common complaints after pelvic organ prolapse surgery. Psyillum fiber is an FDA-approved, over the counter dietary supplement that is commonly used to treat constipation. The investigators are conducting this study to determine if participants who receive psyllium fiber before surgery have less difficulty with their first bowel movement after surgery.

NCT ID: NCT04882982 Completed - Menopause Clinical Trials

Caria: Digital Intervention for Menopause Symptom

Start date: February 1, 2022
Phase: N/A
Study type: Interventional

Menopause is the time of life when menstrual cycles cease. Women typically spend 30-40% of their lives in menopause. Individual experiences of menopause vary and although some women do not experience any significant symptoms, common symptoms include vasomotor dysfunction, vaginal dryness, mood changes, sleep disturbances, urinary incontinence, cognitive changes, somatic complaints and sexual dysfunction. Reduced quality of life can occur as a result of these symptoms. A mobile app has been developed to reduce the impact of these symptoms using a variety of behavioral change techniques including education, goal setting, motivational enhancement, social support and cognitive behavioral approaches. Participants will complete self report assessments of women's symptoms and QOL at baseline, 3 weeks and 6 weeks of app use.

NCT ID: NCT04882917 Completed - Clinical trials for Advanced Solid Tumors

First-in-human Study of M4076 in Advanced Solid Tumors (DDRiver Solid Tumors 410)

Start date: May 24, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), maximum tolerated dose (MTD) (if reached) and early signs of efficacy of M4076 monotherapy in participants with solid tumors in dose escalation (Part 1A). Once the recommended dose for expansion (RDE) is declared in Part 1A, a preliminary food effect cohort, Part 1B, will follow at the RDE determined from Part 1A.